Standout Papers

Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-infe... 2024 202642
  1. Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial (2024)
    Cissy Kityo, Ivan Mambule et al. The Lancet Infectious Diseases

Immediate Impact

2 by Nobel laureates 15 from Science/Nature 54 standout
Sub-graph 1 of 23

Citing Papers

Mechanisms of long COVID and the path toward therapeutics
2024 Standout
Sepsis and Septic Shock
2024 Standout
2 intermediate papers

Works of Cissy Kityo being referenced

Plasma Biomarkers of Human Immunodeficiency Virus–Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy
2019
Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study
2016

Author Peers

Author Last Decade Papers Cites
Cissy Kityo 4443 2797 1567 195 5.5k
Peter Mugyenyi 3933 2163 1863 130 5.1k
Sharon Nachman 3647 1456 2052 158 5.3k
Praphan Phanuphak 4608 2751 2729 273 7.3k
Sundhiya Mandalia 2835 1627 1598 157 5.6k
Avy Violari 2755 1429 1583 118 4.0k
Stefan Z. Wiktor 3360 1790 2569 106 5.3k
Philippa Musoke 4358 2566 1471 146 5.3k
Richard Marlink 4117 3572 1720 126 5.8k
Andrew Zolopa 5493 3612 1883 106 6.8k
John S. Lambert 2378 1511 1643 210 4.7k

All Works

Loading papers...

Rankless by CCL
2026